Determining the specificity of HLA antibodies is arguably one of the most important contributions by the HLA laboratory today. For patients that have low-to-moderate levels of antibody, using a ...
Antiverse Ltd (Antiverse), a biotechnology company developing a computational antibody drug discovery platform, today announced the successful identification of functional antibody clusters targeting ...
How could we forget the SARS-CoV-2 pandemic, right? It’s now part of our history, a story to pass on to the next generation. There are hundreds of related SARS-CoV strains known to infect different ...
Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform ...
Virus neutralizing assays (VNAs) are the gold standard for screening serum for neutralizing antibodies in vitro. These are being used, in many cases, to treat early coronavirus disease 2019 (COVID-19) ...
Although the different SARS-CoV-2 variants currently in circulation are undoubtedly less severe in vaccinated individuals in the general population, immunocompromised people are at greater risk of ...
Biocytogen introduces AI-powered RenSuper platform and industry-first fully automated antibody discovery infrastructure: Beijing, China Wednesday, May 27, 2026, 18:00 Hrs [IST] Bi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results